首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >Questionnaire based quality assurance for the RT01 trial of dose escalation in conformal radiotherapy for prostate cancer (ISRCTN 47772397).
【24h】

Questionnaire based quality assurance for the RT01 trial of dose escalation in conformal radiotherapy for prostate cancer (ISRCTN 47772397).

机译:基于问卷的质量保证,用于前列腺癌保形放射治疗中的RT01剂量递增试验(ISRCTN 47772397)。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND AND PURPOSE: In order to ensure the validity of the outcome of the Medical Research Council's 'RTO1 trial' of dose escalation in conformal radiotherapy for prostate cancer it was considered important that the quality of treatment delivery should meet an adequate standard across all contributing centres. A questionnaire was therefore devised to ensure that all aspects of the planning and delivery process were adequately covered. PATIENTS AND METHODS: The questionnaire considered each step in the planning and delivery process and drew the attention of the participants to the specific requirements of the trial. Before entering patients into the trial each participating centre had to complete the questionnaire and an outlining exercise (reported elsewhere). RESULTS: It was not practicable to define a detailed universally acceptable protocol for the whole process of delivery of conformal radiotherapy, not least because of the different equipment available for planning and treatment in different centres. The questionnaire identified some areas of difference in practice between centres where there may be a need for the development of a consensus as to best practice, particularly in the area of patient set-up. Occasionally it was necessary to follow up responses to questions that had been misunderstood or inadequately answered, but in most cases these issues proved to be easily resolved. CONCLUSIONS: The questionnaire proved to be a useful self-assessment tool as well as enabling the quality assurance group to ensure that the standards of the trial were being met. Subsequent follow-up visits confirmed the usefulness and validity of this self assessment process.
机译:背景与目的:为了确保医学研究委员会的“ RTO1试验”在前列腺癌保形放射治疗中剂量递增的结果的有效性,人们认为重要的是,所有贡献中心的治疗质量均应达到适当的标准。因此,设计了一份调查问卷,以确保充分涵盖计划和交付过程的所有方面。病人和方法:问卷考虑了计划和交付过程中的每个步骤,并提请参与者注意试验的具体要求。在让患者参加试验之前,每个参与中心都必须完成调查表和概述练习(在其他地方报告)。结果:为保形放射治疗的整个交付过程定义详细的普遍接受的协议是不切实际的,尤其是由于在不同中心可用于计划和治疗的设备不同。问卷调查表确定了各中心之间在实践上的一些差异,在这些方面可能需要就最佳实践达成共识,尤其是在患者设置方面。有时有必要跟进对被误解或回答不充分的问题的回答,但是在大多数情况下,这些问题很容易解决。结论:问卷被证明是一种有用的自我评估工具,并且使质量保证小组能够确保达到试验标准。随后的后续访问证实了这种自我评估过程的有用性和有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号